The detection rate of sentinel lymph node in endometrial cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20210121001

Enrollment

Registered

2021-01-21

Start date

2019-11-19

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial cancer Endometrial cancer

Interventions

Sentinel lymph node biopsy procedure were after anesthetic medthod was given, patient was placed in lithotomy position. Peritoneal cavity was accessed by 4-5 port procedure in laparoscopy or extended

Diagnostic

Sentinel lymph node biopsy

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Endometrial cancer patients who under go surgery No prior treatment with radiotherapy, chemotherapy, hormonal therapy No history of pelvic nor para-aortic lymphadenectomy

Exclusion criteria

Exclusion criteria: Petients who has contraindication for Indocyanine green(ICG) injection(allergy, hepatic impairment)

Design outcomes

Primary

Measure	Time frame
Detection rate 2 months after complete intervention Detection rate	—

Secondary

Measure	Time frame
Accuracy 2 months after complete intervention False negative rate	—

Countries

Thailand

Contacts

Public ContactAtthapon Jaishuen

Siriraj hospital

ajaishuen@hotmail.com0850639963

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026